Skip to main content
. 2012 Jun 29;7(6):e39981. doi: 10.1371/journal.pone.0039981

Table 3. Relation between clinicopathological factors and TCF-4J and K expression in patients.

Group No TCF-4J TCF-4K
Level P value Level P value
Age (y) ≤56 23 1.00±0.38 0.2764 0.22±0.23 0.1798
57≤ 24 0.88±0.38 0.31±0.21
Gender M 35 0.93±0.41 0.8270 0.27±0.22 0.9107
F 12 0.96±0.27 0.26±0.24
Virus HBV 29 0.98±0.40 0.1991 0.23±0.22 0.1331
HCV 17 0.83±0.34 0.33±0.21
Tumorsize (mm) ≤30 17 0.83±0.28 0.1446 0.35±0.19 0.0481
30< 30 1.00±0.42 0.22±0.23
Vascularinvasion 36 0.88±0.35 0.0521 0.28±0.21 0.3975
+ 11 1.13±0.41 0.21±0.26
Histology WD, MD 29 0.82±0.35 0.0083 0.35±0.18 0.0001
PD 18 1.12±0.36 0.12±0.21
Liverbackground Normal, CH 24 0.98±0.40 0.3997 0.26±0.23 0.9985
LC 23 0.89±0.36 0.26±0.22

Abbreviations: CH, chronic hepatitis; HBV, hepatitis B virus; HCV, hepatitis C virus; LC, liver cirrhosis; MD, moderately differentiated; PD, poorly differentiated; WD, well differentiated.